Capital Fund Management S.A. acquired a new position in Dolby Laboratories (NYSE:DLB - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 36,396 shares of the electronics maker's stock, valued at approximately $2,923,000.
Other institutional investors have also recently modified their holdings of the company. Alpine Bank Wealth Management purchased a new stake in shares of Dolby Laboratories in the first quarter valued at approximately $25,000. Cheviot Value Management LLC purchased a new stake in shares of Dolby Laboratories in the first quarter valued at approximately $27,000. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Dolby Laboratories in the first quarter worth approximately $29,000. Global X Japan Co. Ltd. acquired a new stake in shares of Dolby Laboratories in the first quarter worth approximately $51,000. Finally, Fifth Third Bancorp boosted its stake in shares of Dolby Laboratories by 84.7% in the first quarter. Fifth Third Bancorp now owns 665 shares of the electronics maker's stock worth $53,000 after acquiring an additional 305 shares during the last quarter. 58.56% of the stock is currently owned by hedge funds and other institutional investors.
Dolby Laboratories Trading Down 1.1%
Dolby Laboratories stock traded down $0.77 during midday trading on Friday, hitting $71.37. The stock had a trading volume of 134,234 shares, compared to its average volume of 431,071. The stock has a market cap of $6.84 billion, a P/E ratio of 26.14 and a beta of 0.91. The business has a fifty day moving average price of $74.25 and a 200 day moving average price of $76.35. Dolby Laboratories has a 12 month low of $68.24 and a 12 month high of $89.66.
Dolby Laboratories (NYSE:DLB - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The electronics maker reported $0.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.72 by $0.06. The business had revenue of $315.55 million during the quarter, compared to the consensus estimate of $305.23 million. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.The business's revenue was up 9.2% on a year-over-year basis. During the same period in the previous year, the firm posted $0.71 earnings per share. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. On average, equities analysts anticipate that Dolby Laboratories will post 2.94 EPS for the current fiscal year.
Dolby Laboratories Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, August 20th. Shareholders of record on Tuesday, August 12th were given a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date was Tuesday, August 12th. Dolby Laboratories's dividend payout ratio is 48.35%.
Insiders Place Their Bets
In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 25,000 shares of the company's stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $72.31, for a total value of $1,807,750.00. Following the completion of the sale, the chief executive officer directly owned 114,725 shares in the company, valued at $8,295,764.75. This represents a 17.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Shriram Revankar sold 7,000 shares of the company's stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $74.92, for a total value of $524,440.00. Following the completion of the transaction, the senior vice president directly owned 70,435 shares in the company, valued at $5,276,990.20. This represents a 9.04% decrease in their position. The disclosure for this sale can be found here. Insiders sold 148,049 shares of company stock worth $11,045,581 over the last ninety days. Company insiders own 38.39% of the company's stock.
Analysts Set New Price Targets
A number of equities analysts have weighed in on DLB shares. Barrington Research reissued an "outperform" rating and set a $100.00 price objective on shares of Dolby Laboratories in a research note on Friday, May 2nd. Wall Street Zen cut Dolby Laboratories from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Rosenblatt Securities reissued a "buy" rating and issued a $95.00 target price on shares of Dolby Laboratories in a research report on Friday, August 1st. Finally, Tigress Financial increased their price objective on Dolby Laboratories from $112.00 to $114.00 and gave the stock a "buy" rating in a research report on Friday, August 15th. Three analysts have rated the stock with a Buy rating, According to MarketBeat, the company currently has a consensus rating of "Buy" and an average target price of $103.00.
Read Our Latest Research Report on Dolby Laboratories
Dolby Laboratories Profile
(
Free Report)
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Read More

Before you consider Dolby Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.
While Dolby Laboratories currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.